tau/beta amyloid dual aggregation inhibitors (Pharma Eight/Chemgenesis)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nametau/beta amyloid dual aggregation inhibitors (Pharma Eight/Chemgenesis)
Drug Alias NamePE-859
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta amyloid A4 protein aggregation inhibitorsMicrotubule-associated protein tau inhibitors
TargetsMicrotubule-associated protein tauBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharma Eight
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharma EightChemgenesis Inc
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A